BEIJING - After a 10-month investigation, China’s Ministry of Public Security (MPS) has formally charged that GlaxoSmithKline PLC ex-China head Mark Reilly and two Chinese executives offered bribes to boost pharmaceutical sales in China.
Reilly incorporated money used to pay bribes into the cost of drug sales since January 2009 when he became general...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?